Dr. Reddy's Laboratories Stock Shows Mixed Performance Amid Sector Trends
Dr Reddy's Laboratories has shown increased activity today, recovering from three days of decline and trading at Rs 1203.85. Despite this, the stock remains below key moving averages and has experienced a year-long decline of 5.45%. The company has a market capitalization of Rs 1,00,079.00 crore.
Dr Reddy's Laboratories, a prominent player in the Pharmaceuticals & Biotechnology sector, has shown notable activity today, outperforming its sector by 0.41%. After experiencing three consecutive days of decline, the stock has gained traction, trading consistently at Rs 1203.85. Despite this uptick, Dr Reddy's Laboratories is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a challenging trend in the short to medium term. The company's market capitalization stands at Rs 1,00,079.00 crore, categorizing it as a large-cap entity.
In terms of valuation, Dr Reddy's has a price-to-earnings (P/E) ratio of 17.34, significantly lower than the industry average of 35.13. Over the past year, the stock has declined by 5.45%, contrasting with the Sensex's positive performance of 5.06%. Additionally, year-to-date performance reflects a decrease of 13.99%, while the Sensex has gained 7.19%.
Overall, Dr Reddy's Laboratories continues to navigate a complex market landscape, with its recent performance reflecting broader industry trends.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
